Cite
HARVARD Citation
Wang, V. et al. (2017). Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden. Journal for immunotherapy of cancer. 5 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, V. et al. (2017). Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden. Journal for immunotherapy of cancer. 5 (1), p. . [Online].